Table 4 Prevalence rates of frequent exacerbators and SABA over-users by practice

From: Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations

 

Total number of registered patients

Active asthma patients, number (%)

Frequent exacerbators in each practice (%)

SABA over-users in each practice (%)

Patients living in 15% most deprived data zones in the SIMD ranking (%)

Practice 1

5450

251 (5)

4

3

10.2

Practice 2

11,574

583 (5)

4

2

5.5

Practice 3

3144

170 (5)

6

4

18

Practice 4

4644

214 (5)

7

2

10.6

Practice 5

6714

349 (5)

7

5

34.4

Practice 6

2478

136 (5)

7

10

20.5

Practice 7

2224

144 (6)

8

8

70

Practice 8

3088

225 (7)

8

9

71.8

Practice 9

5061

293 (6)

8

9

58

Practice 10

4085

274 (7)

14

5

36.9

  1. SABA short-acting beta-2 agonist, SIMD Scottish Index of Multiple Deprivation